Tuberkulose, bakterieinfektioner, inklusive sepsis og pneumoni, invasive svampeinfektioner og andre opportunistiske infektioner er set hos patienter behandlet med infliximab.
Tuberculosis, bacterial infections, including sepsis and pneumonia, invasive fungal infections, and other opportunistic infections have been observed in patients treated with infliximab.